Big Cypress Acquisition Corp

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Big Cypress Acquisition Corp
TickerSABS
CIK #0001833214
CUSIP78397T202
SectorReal Estate & Construction - Blank Checks
Address300 W 41St Street Suite 202, Miami Beach, FL 33140
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
SAB Biotherapeutics Inc 2025-08-05 175.0 M Exemption: 506(b) · Duration: One year or less · Commission: $10,500,000 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001833214] 10-K
[0001833214] 10-Q
[0001833214] 3
[0001833214] 4
[0001833214] 5
[0001833214] 8-K
[0001833214] D
[0001833214] SC 13D
[0001833214] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Balyasny Asset Management LP SAB Biotherapeutics Inc [2026-05-15] 0.0
Caligan Partners LP SAB Biotherapeutics Inc [2026-05-15] 0.0
Millennium Management LLC SAB Biotherapeutics Inc [2026-05-01] 0.0
Perceptive Advisors LLC SAB Biotherapeutics Inc [2026-01-22] 0.0
Woodline Partners LP SAB Biotherapeutics Inc [2025-11-14] 0.0
Commodore Capital LP SAB Biotherapeutics Inc [2025-10-03] 0.0
RA Capital Management LP SAB Biotherapeutics Inc [2025-10-03] 0.0
Vivo Opportunity Fund Holdings LP SAB Biotherapeutics Inc [2025-10-03] 0.0
RTW Investments LP SAB Biotherapeutics Inc [2024-02-14] 0.99
Biotechnology Value Fund L P SAB Biotherapeutics Inc [2023-12-04] 5.3
Commodore Capital LP SAB Biotherapeutics Inc [2023-10-16] 0.9
Big Cypress Holdings LLC SAB Biotherapeutics Inc [2021-11-02] 7.0
Sullivan Eddie Joe SAB Biotherapeutics Inc [2021-11-01] 13.12
Hamilton Christine E SAB Biotherapeutics Inc [2021-11-01] 24.58
Radcliffe Capital Management LP Big Cypress Acquisition Corp [2021-10-19] 8.77
Basso Capital Management LP Big Cypress Acquisition Corp [2021-02-24] 5.12
Form 3/4/5 Filer 2011 - 2026
SAB Biotherapeutics Inc
Kropotova Alexandra
to Lucy
Sullivan Eddie Joe
Reich Samuel J
Bausch Christoph Lawrence
Zaccardelli David
Jain Rita
Ellias Helen K
Link David
Giberson Scott
Lucera Erick
Polvino William James
Skyler Jay S
Moin Andrew
Sessa Capital Master LP
Petry John
Sessa Capital IM GP LLC
Sessa Capital IM LP
Sessa Capital GP LLC
Hamilton Christine E
Spragens Jeffrey G
Link David Charles
Conley Mark William
King Michael
Beyer Russell P
Ullerich Melissa Vera
Erickson Bruce Kipp
Finnegan Frederick
Luke Thomas Charles
Pommer Jerry Lynn
Carillo Carlos N
Turner Mervyn
Randall Charles Hiram
Hamilton Edward D
Wu Hua
Katz Ilan
Big Cypress Holdings LLC
Collins Stephen D
Martin James Joseph
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Kropotova Alexandra
Common Stock
2026-03-24 Tax withheld 988
Reich Samuel J
Stock option (right to buy) · derivative
2026-02-03 Grant 4,800,000 $0.00
Kropotova Alexandra
Stock option (right to buy) · derivative
2026-02-03 Grant 2,400,000 $0.00
to Lucy
Stock option (right to buy) · derivative
2026-02-03 Grant 2,400,000 $0.00
Sullivan Eddie Joe
Stock option (right to buy) · derivative
2026-02-03 Grant 3,000,000 $0.00
Bausch Christoph Lawrence
Stock option (right to buy) · derivative
2026-02-03 Grant 1,800,000 $0.00
Jain Rita
Stock Option (right to buy) · derivative
2026-01-05 Grant 240,000 $0.00
Zaccardelli David
Stock Option (right to buy) · derivative
2026-01-05 Grant 240,000 $0.00
Polvino William James
Stock Option (right to buy) · derivative
2025-12-16 Grant 150,000 $0.00
Skyler Jay S
Stock Option (right to buy) · derivative
2025-12-16 Grant 150,000 $0.00
Lucera Erick
Stock option (right to buy) · derivative
2025-12-16 Grant 150,000 $0.00
Ellias Helen K
Stock Option (right to buy) · derivative
2025-12-16 Grant 150,000 $0.00
Giberson Scott
Stock Option (right to buy) · derivative
2025-12-16 Grant 150,000 $0.00
Link David
Stock Option (right to buy) · derivative
2025-12-16 Grant 150,000 $0.00
Kropotova Alexandra
Common Stock
2025-12-11 Tax withheld 988
Moin Andrew
Common Stock
2025-09-29 Option exercise 1,740,000 $1.75 3,045,000
Sessa Capital Master LP +4
Common Stock
2025-09-29 Option exercise 1,740,000 $1.75 3,045,000
Moin Andrew
Series B Convertible Preferred Stock · derivative
2025-09-29 Option exercise 17,400
Sessa Capital Master LP +4
Series B Convertible Preferred Stock · derivative
2025-09-29 Option exercise 17,400
Common Stock
2025-09-19 Tax withheld 1,977
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 79 69,764,794
2025-12-31 48 36,342,111
2025-09-30 34 28,024,025
2025-06-30 26 1,923,784
2025-03-31 27 2,209,552
2024-12-31 26 2,633,099
2024-09-30 26 3,141,852
2024-06-30 23 3,127,263
2024-03-31 25 3,342,174
2023-12-31 43 34,795,639
2023-09-30 35 3,016,240
2023-06-30 39 3,150,975
Form 13F Holdings
Firm Period DFND Voting Shares
Simplify Asset Management Inc [2026-06-30] SOLE 104,849 104,849
IFP Advisors LLC [2026-06-30] SOLE 38,699 38,699
First PREMIER Bank [2026-06-30] SOLE 18,986 18,986
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com